✦ LIBER ✦

Discovery of a 1 H -Benzoimidazol-2-yl)-1 H -pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

✍ Scribed by Wittman, Mark; Carboni, Joan; Attar, Ricardo; Balasubramanian, Balu; Balimane, Praveen; Brassil, Patrick; Beaulieu, Francis; Chang, Chiehying; Clarke, Wendy; Dell, Janet; Eummer, Jeffrey; Frennesson, David; Gottardis, Marco; Greer, Ann; Hansel, Steven; Hurlburt, Warren; Jacobson, Bruce; Krishnananthan, Subramaniam; Lee, Francis Y.; Li, Aixin; Lin, Tai-An; Liu, Peiying; Ouellet, Carl; Sang, Xiaopeng; Saulnier, Mark G.; Stoffan, Karen; Sun, Yax; Velaparthi, Upender; Wong, Henry; Yang, Zheng; Zimmermann, Kurt; Zoeckler, Mary; Vyas, Dolatrai

Book ID: 119944369
Publisher: American Chemical Society
Year: 2005
Tongue: English
Weight: 156 KB
Volume: 48
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm050392q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Evaluation of 4-(2-(4-chlo

Discovery and Evaluation of 4-(2-(4-chloro-1 H -pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1 H -benzo[ d ]imidazol-2-yl)pyridin-2(1 H )-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity

✍ Velaparthi, Upender; Wittman, Mark; Liu, Peiying; Carboni, Joan M.; Lee, Francis 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 205 KB

Discovery and Initial SAR of 3-(1H-Benzo

Discovery and Initial SAR of 3-(1H-Benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as Inhibitors of Insulin-Like Growth Factor 1-Receptor (IGF-1R).

✍ Upender Velaparthi; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 22 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Discovery of 4-{4-[3-(Pyridin-2-yl)-1 H

Discovery of 4-{4-[3-(Pyridin-2-yl)-1 H -pyrazol-4-yl]pyridin-2-yl}- N -(tetrahydro-2 H - pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor

✍ Gellibert, Françoise; de Gouville, Anne-Charlotte; Woolven, James; Mathews, Neil 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 561 KB

Discovery of Brivanib Alaninate (( S )-(

Discovery of Brivanib Alaninate (( S )-(( R )-1-(4-(4-Fluoro-2-methyl-1 H -indol-5-yloxy)-5-methylpyrrolo[2,1- f ][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)

✍ Cai, Zhen-wei; Zhang, Yongzheng; Borzilleri, Robert M.; Qian, Ligang; Barbosa, S 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 243 KB

Discovery and Preclinical Evaluation of

Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1 H -indazol-5-ylamino]-5-methylpyrrolo[2,1- f ][1,2,4]triazin-6-yl]carbamic Acid, (3 S )-3-Morpholinylmethyl Ester (BMS-599626), a Selective and Orally Efficacious Inhibitor of Human Epidermal Growth Factor Receptor 1 and 2 Kinases

✍ Gavai, Ashvinikumar V.; Fink, Brian E.; Fairfax, David J.; Martin, Gregory S.; R 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 912 KB

A phase 2 study of the insulin-like grow

A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors

✍ Diane L. Reidy-Lagunes; Efsevia Vakiani; Michal F. Segal; Ellen M. Hollywood; La 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB